Description

Alfort Dexa (dexketoprofen trometamol) solution for injections 50 mg/2 ml. ampoules 2 ml. №5

Ingredients:

Each 2 ml ampoule contains 50 mg of dexketoprofen trometamol.

Dosage:

The usual dose is 50 mg (1 ampoule) administered by intramuscular injection once daily.

Indications:

Alfort Dexa is indicated for the treatment of moderate to severe pain. It is commonly used postoperatively or in conditions where oral administration is not feasible.

Contraindications:

Do not use Alfort Dexa in patients with a history of hypersensitivity to dexketoprofen or other NSAIDs. It is contraindicated in patients with active peptic ulcers or gastrointestinal bleeding.

Directions:

Administer Alfort Dexa by deep intramuscular injection. Do not exceed the recommended dose or duration of treatment. It should be used with caution in the elderly and in patients with renal or hepatic impairment.

Scientific Evidence:

Studies have shown that dexketoprofen trometamol, the active ingredient in Alfort Dexa, is effective in providing analgesia in various pain conditions. A study by Lanas et al. (2004) demonstrated the superior efficacy of dexketoprofen over placebo in postoperative pain management.

Additional Information:

Alfort Dexa acts by inhibiting the enzyme cyclooxygenase, thereby reducing the production of prostaglandins involved in the inflammatory process. This results in pain relief and anti-inflammatory effects. Compared to other NSAIDs, dexketoprofen has shown to have a rapid onset of action and good tolerability profile.

Clinical trials have also highlighted the safety and efficacy of Alfort Dexa in providing effective pain relief with a low incidence of adverse effects. Patients receiving Alfort Dexa reported significant improvements in pain scores and overall quality of life, making it a valuable option in pain management protocols.